131 related articles for article (PubMed ID: 9741952)
1. Inhibition of murine hepatic cytochrome P450 activities by natural and synthetic phenolic compounds.
Baer-Dubowska W; Szaefer H; Krajka-Kuzniak V
Xenobiotica; 1998 Aug; 28(8):735-43. PubMed ID: 9741952
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of liver monooxygenases by beta-ionone, 1,8-cineole, (-)-menthol and terpineol.
De-Oliveira AC; Fidalgo-Neto AA; Paumgartten FJ
Toxicology; 1999 Jul; 135(1):33-41. PubMed ID: 10454222
[TBL] [Abstract][Full Text] [Related]
3. The alkaloid rutaecarpine is a selective inhibitor of cytochrome P450 1A in mouse and human liver microsomes.
Ueng YF; Jan WC; Lin LC; Chen TL; Guengerich FP; Chen CF
Drug Metab Dispos; 2002 Mar; 30(3):349-53. PubMed ID: 11854157
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes.
Dhawan A; Parmar D; Dayal M; Seth PK
Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197
[TBL] [Abstract][Full Text] [Related]
6. Modulation by phytochemicals of cytochrome P450-linked enzyme activity.
Teel RW; Huynh H
Cancer Lett; 1998 Nov; 133(2):135-41. PubMed ID: 10072162
[TBL] [Abstract][Full Text] [Related]
7. Kinetics and selectivity of mechanism-based inhibition of guinea pig hepatic and pulmonary cytochrome P450 by N-benzyl-1-aminobenzotriazole and N-alpha-methylbenzyl-1-aminobenzotriazole.
Sinal CJ; Bend JR
Drug Metab Dispos; 1996 Sep; 24(9):996-1001. PubMed ID: 8886610
[TBL] [Abstract][Full Text] [Related]
8. Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by o-toluidine.
Szaefer H; Jodynis-Liebert J; Cichocki M; Matuszewska A; Baer-Dubowska W
Toxicology; 2003 Apr; 186(1-2):67-77. PubMed ID: 12604171
[TBL] [Abstract][Full Text] [Related]
9. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver.
Oetari S; Sudibyo M; Commandeur JN; Samhoedi R; Vermeulen NP
Biochem Pharmacol; 1996 Jan; 51(1):39-45. PubMed ID: 8534266
[TBL] [Abstract][Full Text] [Related]
10. The effects of inhalation exposure to bromo-dichloromethane on specific rat CYP isoenzymes.
Allis JW; Brown BL; Zhao G; Pegram RA
Toxicology; 2001 Mar; 161(1-2):67-77. PubMed ID: 11295256
[TBL] [Abstract][Full Text] [Related]
11. Inhibition and inactivation of murine hepatic ethoxy- and pentoxyresorufin O-dealkylase by naturally occurring coumarins.
Cai Y; Bennett D; Nair RV; Ceska O; Ashwood-Smith MJ; DiGiovanni J
Chem Res Toxicol; 1993; 6(6):872-9. PubMed ID: 8117927
[TBL] [Abstract][Full Text] [Related]
12. A comparative study of constitutive and induced alkoxyresorufin O-dealkylation and individual cytochrome P450 forms in cynomolgus monkey (Macaca fascicularis), human, mouse, rat and hamster liver microsomes.
Weaver RJ; Thompson S; Smith G; Dickins M; Elcombe CR; Mayer RT; Burke MD
Biochem Pharmacol; 1994 Mar; 47(5):763-73. PubMed ID: 8135852
[TBL] [Abstract][Full Text] [Related]
13. Modulation of 3-methylcholanthrene-induced rat hepatic and renal cytochrome P450 and phase II enzymes by plant phenols: protocatechuic and tannic acids.
Krajka-Kuźniak V; Szaefer H; Baer-Dubowska W
Toxicol Lett; 2004 Sep; 152(2):117-26. PubMed ID: 15302093
[TBL] [Abstract][Full Text] [Related]
14. Different profiles of hepatic alkoxyresorufin O-dealkylase activities in small rodents.
Chatuphonprasert W; Rermraksakul P; Udomsuk L; Lao-ong T; Jarukamjorn K
J Appl Toxicol; 2012 Dec; 32(12):1002-7. PubMed ID: 22610983
[TBL] [Abstract][Full Text] [Related]
15. Hepatic ethoxy-, methoxy- and pentoxyresorufin O-dealkylase activities in Landrace and Duroc pigs stimulated with HCG.
Zamaratskaia G; Zlabek V; Ropstad E; Tajet H; Andresen Ø
Reprod Domest Anim; 2010 Dec; 45(6):e269-74. PubMed ID: 19930133
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of rat liver cytochrome P450 isozymes by isothiocyanates and their conjugates: a structure-activity relationship study.
Conaway CC; Jiao D; Chung FL
Carcinogenesis; 1996 Nov; 17(11):2423-7. PubMed ID: 8968058
[TBL] [Abstract][Full Text] [Related]
17. Effects of bioflavonoids on hepatic P450 activities.
Obermeier MT; White RE; Yang CS
Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
[TBL] [Abstract][Full Text] [Related]
18. Oral administration of naturally occurring coumarins leads to altered phase I and II enzyme activities and reduced DNA adduct formation by polycyclic aromatic hydrocarbons in various tissues of SENCAR mice.
Kleiner HE; Vulimiri SV; Miller L; Johnson WH; Whitman CP; DiGiovanni J
Carcinogenesis; 2001 Jan; 22(1):73-82. PubMed ID: 11159744
[TBL] [Abstract][Full Text] [Related]
19. The inhibition of CYP enzymes in mouse and human liver by pilocarpine.
Kimonen T; Juvonen RO; Alhava E; Pasanen M
Br J Pharmacol; 1995 Feb; 114(4):832-6. PubMed ID: 7773543
[TBL] [Abstract][Full Text] [Related]
20. In vivo cimetidine inhibits hepatic CYP2C6 and CYP2C11 but not CYP1A1 in adult male rats.
Levine M; Law EY; Bandiera SM; Chang TK; Bellward GD
J Pharmacol Exp Ther; 1998 Feb; 284(2):493-9. PubMed ID: 9454789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
